Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?

Future Medicinal Chemistry
Chiara NardonDolores Fregona

Abstract

In the last years, several metal-based compounds have been designed and biologically investigated worldwide in order to obtain chemotherapeutics with a better toxicological profile and comparable or higher antiblastic activity than the clinically-established platinum-based drugs. In this context, researchers have addressed their attention to alternative nonplatinum derivatives able to maximize the anticancer activity of the new drugs and to minimize the side effects. Among them, a number of ruthenium complexes have been developed, including the compounds NAMI-A and KP1019, now in clinical trials. Here, we report the results collected so far for a particular class of ruthenium complexes - the ruthenium(II/III)-dithiocarbamates - which proved more potent than cisplatin in vitro, even at nanomolar concentrations, against a wide panel of human tumor cell lines.

References

Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R F Borch, M E Pleasants
Apr 26, 1969·Nature·B RosenbergV H Mansour
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R F BorchM E Pleasants
Jan 1, 1983·European Journal of Nuclear Medicine·P SomA B Brill
Jan 1, 1980·Journal of Inorganic Biochemistry·M J ClarkeA D Kelman
Jul 1, 1995·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·L P RybakS M Somani
Nov 1, 1995·The Journal of Clinical Investigation·H SakuraiN Miyasaka
Nov 1, 1995·Environmental Health Perspectives·R A GoyerJ R Reigart
Jun 19, 2001·Mutation Research·M Kartalou, J M Essigmann
Oct 25, 2001·The Journal of Organic Chemistry·Eduardo HumeresM. Marta de S. Sierra
May 25, 2002·The Journal of Organic Chemistry·Eduardo HumeresAdriano Martendal
Jul 10, 2002·Progress in Nucleic Acid Research and Molecular Biology·Viktor Brabec
Nov 9, 2002·Journal of Applied Toxicology : JAT·N SegoviaM Espigares
Aug 2, 1952·Nature·F P DWYERJ H KOCH
Nov 1, 2003·Journal of Environmental Monitoring : JEM·Vaneet Kumar SharmaAshok Kumar Malik
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeany M Rademaker-LakhaiJan H M Schellens
Dec 8, 2004·Current Topics in Medicinal Chemistry·Celine J MarmionSimon P Fricker
Mar 29, 2006·Dalton Transactions : an International Journal of Inorganic Chemistry·Petra SchlugaBernhard K Keppler
Jun 23, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Viktor Brabec, Olga Nováková
Jan 21, 2009·Dalton Transactions : an International Journal of Inorganic Chemistry·Lorena GiovagniniDolores Fregona
Feb 18, 2010·Molecular Pharmacology·Stephen B HowellMichael J Sailor
Mar 10, 2010·Cancer Chemotherapy and Pharmacology·Emmanuel S Antonarakis, Ashkan Emadi
Jul 2, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Nial J WheateRabbab Oun
Sep 18, 2010·Current Medicinal Chemistry·J Costa Pessoa, I Tomaz
Jul 7, 2009·Metallomics : Integrated Biometal Science·Lalla Aicha BaClaus Jacob
Jun 1, 2009·Future Medicinal Chemistry·Simon M PagePaul D Barker
Jun 2, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Alberta Bergamo, Gianni Sava
Oct 6, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Eszter Márta NagyDolores Fregona
Nov 2, 2011·Current Topics in Medicinal Chemistry·Christian G HartingerAlexey A Nazarov
Jul 14, 2012·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Soledad Betanzos-LaraAbraha Habtemariam
Aug 31, 2012·Mini Reviews in Medicinal Chemistry·Graeme Hogarth
Aug 31, 2012·Mini Reviews in Medicinal Chemistry·Eszter Márta NagyDolores Fregona
Mar 6, 2013·Journal of Cellular Physiology·Scott K ParksJacques Pouysségur
Jan 25, 2014·Chemical Reviews·Katja Dralle Mjos, Chris Orvig
Mar 13, 2014·Current Opinion in Chemical Biology·Nafees Muhammad, Zijian Guo
Jun 18, 2014·Redox Biology·James R Roede, Dean P Jones
Jul 25, 2014·European Journal of Pharmacology·Shaloam Dasari, Paul Bernard Tchounwou
Sep 26, 2014·Molecular Biology Reports·Hanh NgoTom C Karagiannis
Nov 7, 2014·Mini Reviews in Medicinal Chemistry·Veenu BalaVishnu L Sharma
Mar 10, 2015·Harvard Review of Psychiatry·Robert M Swift, Elizabeth R Aston
May 15, 2015·ChemistryOpen·Chiara NardonDolores Fregona

❮ Previous
Next ❯

Methods Mentioned

BETA
column chromatography
electron paramagnetic resonance
xenografts

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.